Clinical Trial to Demonstrate the Safety and Performance of REGENERA Breast Implant in 40-70 Years Old Women Affected by Malignant Breast Lesion Treated by Lumpectomy
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Mastectomy, Segmental|Breast Neoplasm Malignant Female
Interventions: DEVICE: REGENERA breast implant implantation
Sponsor: Tensive SRL